Kaluza C Analysis Software, 5-User (Network)

C10577


Kaluza C Analysis Software is a stand-alone program supporting data analysis from any Flow Cytometry Standard (FCS)-compliant file, regardless of the manufacturer. This software is listed with the FDA as a medical device supporting the compliance needs of the clinical flow cytometry laboratory. This full-featured high-performance package has improved processing capabilities, but also specialized functions for a clinical workflow.  The robust QC reporting capabilities support instrument and assay verification records and streamline audit preparation activities.  Master report layouts establish standardized reporting and save technician’s time in creating reports.  The software integrates with the Laboratory Information System (LIS) and can export user defined statistics and graphs. Value pricing available for bundle of 5 concurrent seats, controled by the Network License Control Center, for the current released version at the time of purchase in perpetuity.

Specifications

Platform Flow Analysis Acquisition
Package Quantity 1

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.